The research demonstrated that the colchicine delivery system encapsulated in nanoparticles effectively reduced the levels of serum C-reactive protein (CRP), tumor necrosis Factor-alpha (TNF-α), and IL-1β, decreased the infarct area by 45%, and alleviated myocardial fibrosis [21]. This evidence concerns the gene IL1B and Myocardial fibrosis.